OncologyTyrosine kinase inhibitorScheduled campaign
Imatinib mesylate
Also known as Gleevec, Glivec
A tyrosine kinase inhibitor indicated for chronic myeloid leukaemia (CML) and gastrointestinal stromal tumours (GIST). Manufactured with controlled α-polymorph.
Full specification
Identity, quality, and supply.
- INN
- Imatinib mesylate
- CAS number
- 220127-57-1
- Molecular formula
- C29H31N7O·CH4O3S
- Molecular weight
- 589.7 g/mol
- Therapeutic area
- Oncology
- Therapeutic class
- Tyrosine kinase inhibitor
- Supplied as
- API
- Available scale
- Commercial
- Stock status
- Scheduled campaign
- Storage
- As per COA
- Packaging
- HDPE drums, 5 kg net weight
- Brand names
- Gleevec, Glivec
Highlights
What buyers care about.
- α-polymorph control, XRPD per batch
- Full impurity profile characterised
Related molecules
Full catalogue